Bing He

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Top Venues

Medical review (Berlin, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Xing Wang, Feiyang Deng, Tianyi Ji, Chengning Zhang, Yang Tian, Hui Zhang, Aiping Zheng, Ying Chen, Bing He, Wenbing Dai, Hua Zhang, Qiang Zhang, Xueqing Wang
Impact of Physiological Characteristics on Chylomicron Pathway-Mediated Absorption of Nanocrystals in the Pediatric Population. ACS nano (2024)
Xing Wang, Feiyang Deng, Tianyi Ji, Chengning Zhang, Yang Tian, Hui Zhang, Aiping Zheng, Ying Chen, Bing He, Wenbing Dai, Hua Zhang, Qiang Zhang, Xueqing Wang
Impact of Physiological Characteristics on Chylomicron Pathway-Mediated Absorption of Nanocrystals in the Pediatric Population. ACS nano 18 (34) (2024)
Minghui Li, Anna Jiang, Huize Han, Meifang Chen, Bing Wang, Yuxi Cheng, Hua Zhang, Xueqing Wang, Wenbing Dai, Wei Yang, Qiang Zhang, Bing He
A Trinity Nano-Vaccine System with Spatiotemporal Immune Effect for the Adjuvant Cancer Therapy after Radiofrequency Ablation. ACS nano (2023)
Chang Yang, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang, Wenbing Dai
IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review. Pharmaceutics 15 (1) (2023)
Chang Yang, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang, Wenbing Dai
IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review. Pharmaceutics 15 (1) (2023)
Chang Yang, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang, Wenbing Dai
IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review. Pharmaceutics 15 (1) (2023)
Shumin Fan, Huize Han, Zhicheng Yan, Yao Lu, Bing He, Qiang Zhang
Lipid-based nanoparticles for cancer immunotherapy. Medical review (Berlin, Germany) 3 (3) (2023)